Clemmons Amber
College of Pharmacy, Department of Clinical and Administrative Pharmacy, University of Georgia, Augusta, GA 30912, USA.
Department of Pharmacy, Augusta University Medical Center, Augusta, GA 30912, USA.
Pharmacy (Basel). 2020 Jan 2;8(1):3. doi: 10.3390/pharmacy8010003.
Recently, the required training and credentials for as well as the various roles of the hematopoietic cell transplant (HCT) pharmacist have been endorsed by the leading organizations in cellular therapy, the American Society of Transplant and Cellular Therapy and the European Society of Blood and Bone Marrow Transplantation. While these documents establish the roles a HCT pharmacist can fulfill within the multi-disciplinary team, few reports have evaluated the impact of the HCT pharmacist on clinical, financial, or quality outcomes. Further, a paucity of information has been reported on types of practice models, such as the use of collaborative practice agreements, or described effective methods to overcome the barriers to the increased utilization of HCT pharmacists. Herein, a brief summary of available information is provided to aid readers in understanding the state of the science for pharmacists practicing in this specialty with the goal to stimulate further research to justify the roles of HCT pharmacists and the correlation of such research to various outcome measures. Practitioners are encouraged to build upon this existing knowledge to create the novel integration and elevation of pharmacy practice to improve outcomes for patients, providers, and payors.
最近，细胞治疗领域的领先组织——美国移植与细胞治疗学会和欧洲血液与骨髓移植学会，认可了造血细胞移植（HCT）药师所需的培训、资质以及其各种职责。虽然这些文件确立了HCT药师在多学科团队中所能发挥的作用，但很少有报告评估HCT药师对临床、财务或质量结果的影响。此外，关于实践模式类型（如使用协作实践协议）的信息报道匮乏，也未描述有效方法来克服增加HCT药师利用率的障碍。在此，提供现有信息的简要总结，以帮助读者了解该专业药师的科学现状，目的是激发进一步研究，以证明HCT药师的作用以及此类研究与各种结果指标的相关性。鼓励从业者在此现有知识基础上，实现药学实践的全新整合与提升，以改善患者、医疗服务提供者和支付方的结果。
